IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
Helping clinicians investigate sooner and plan next steps with confidence WESTBROOK, Maine–(BUSINESS WIRE)–IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the availability of the IDEXX Cancer Dx™ Panel in the United Kingdom, beginning with early detection of lymphoma in at-risk* dogs. The blood test can be added to panels … [Read more…]
